XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of reconciliation of cash and cash equivalents
The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December 31, 2022, 2021 and 2020:
In millions202220212020
Cash and cash equivalents$12,945 $9,408 $7,854 
Restricted cash (included in other current assets)144 3,065 2,913 
Restricted cash (included in other assets)216 218 276 
Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows$13,305 $12,691 $11,043 
Schedule of accounts receivable, net Accounts receivable, net was composed of the following at December 31, 2022 and 2021:
In millions20222021
Trade receivables$8,983 $7,932 
Vendor and manufacturer receivables12,395 10,573 
Premium receivables2,676 2,537 
Other receivables3,449 3,389 
   Total accounts receivable, net (1)
$27,503 $24,431 
_____________________________________
(1)Includes accounts receivable of $227 million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 ‘‘Acquisitions, Divestitures and Asset Sales’’ for additional information.
Rollforward of deferred acquisition costs
The following is a roll forward of deferred acquisition costs for the years ended December 31, 2022 and 2021:
In millions20222021
Deferred acquisition costs, beginning of the period$879 $519 
Capitalizations564 529 
Amortization expense(224)(169)
Deferred acquisition costs, end of the period$1,219 $879 
Schedule of property and equipment
Property and equipment consisted of the following at December 31, 2022 and 2021:
In millions20222021
Land$1,996 $2,038 
Building and improvements4,545 4,225 
Fixtures and equipment12,978 13,619 
Leasehold improvements6,238 6,242 
Software8,843 7,426 
Total property and equipment34,600 33,550 
Accumulated depreciation and amortization(21,483)(20,654)
Property and equipment, net (1)
$13,117 $12,896 
_____________________________________
(1)Includes property and equipment of $244 million which have been accounted for as assets held for sale and are included in assets held for sale on the consolidated balance sheet at December 31, 2022. See Note 2 ‘‘Acquisitions, Divestitures and Asset Sales’’ for additional information.
Schedule of disaggregation of revenue
The following table disaggregates the Company’s revenue by major source in each segment for the years ended December 31, 2022, 2021 and 2020:
In millionsHealth Care
Benefits
Health
Services
Pharmacy &
Consumer
Wellness
Corporate/
Other
Intersegment
Eliminations
Consolidated
Totals
2022
Major goods/services lines:
Pharmacy$— $166,793 $83,480 $— $(45,154)$205,119 
Front Store— — 22,780 — — 22,780 
Premiums85,274 — — 56 — 85,330 
Net investment income (loss)476 — (44)406 — 838 
Other5,600 2,783 2,380 68 (2,431)8,400 
Total$91,350 $169,576 $108,596 $530 $(47,585)$322,467 
Health Services distribution channel:
Pharmacy network (1)
$102,968 
Mail & specialty (2)
63,825 
Other2,783 
Total$169,576 
2021
Major goods/services lines:
Pharmacy$— $150,646 $77,886 $— $(43,913)$184,619 
Front Store— — 21,315 — — 21,315 
Premiums76,064 — — 68 — 76,132 
Net investment income586 — 17 596 — 1,199 
Other5,469 3,246 2,402 57 (2,328)8,846 
Total$82,119 $153,892 $101,620 $721 $(46,241)$292,111 
Health Services distribution channel:
Pharmacy network (1)
96,834 
Mail & specialty (2)
53,812 
Other3,246 
Total$153,892 
2020
Major goods/services lines:
Pharmacy$— $139,453 $71,984 $— $(40,350)$171,087 
Front Store— — 19,655 — — 19,655 
Premiums69,301 — — 63 — 69,364 
Net investment income483 — — 315 — 798 
Other5,625 1,901 1,940 48 (1,712)7,802 
Total$75,409 $141,354 $93,579 $426 $(42,062)$268,706 
Health Services distribution channel:
Pharmacy network (1)
89,740 
Mail & specialty (2)
49,713 
Other1,901 
Total$141,354 
_____________________________________________
(1)Health Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company’s retail pharmacies and LTC pharmacies. Effective January 1, 2023, pharmacy network also includes activity associated with Maintenance Choice®, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order. Maintenance Choice activity was previously reflected in mail & specialty. Segment financial information has been revised to reflect these changes.
(2)Health Services mail & specialty is defined as specialty mail claims inclusive of Specialty Connect® claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy & Consumer Wellness segment. Effective January 1, 2023, mail & specialty excludes Maintenance Choice activity, which is now reflected within pharmacy network. Segment financial information has been revised to reflect these changes.
Schedule of receivables and contract liabilities from contracts with customers
The following table provides information about receivables and contract liabilities from contracts with customers as of December 31, 2022 and 2021:
In millions20222021
Trade receivables (included in accounts receivable, net)$8,983 $7,932 
Contract liabilities (included in accrued expenses)71 87 

During the years ended December 31, 2022 and 2021, the contract liabilities balance includes increases related to customers’ earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:
In millions20222021
Contract liabilities, beginning of period$87 $71 
Rewards earnings and gift card issuances340 387 
Redemption and breakage(356)(371)
Contract liabilities, end of period$71 $87 
Schedule of variable interest entities
Other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December 31, 2022 and 2021 were as follows:
In millions20222021
Hedge fund investments$589 $463 
Private equity investments707 601 
Real estate partnerships241 225 
Total$1,537 $1,289 
Schedule of discontinued operations
Below is a summary of the results of discontinued operations for the year ended December 31, 2020.
In millions2020
Loss from discontinued operations$(12)
Income tax benefit
Loss from discontinued operations, net of tax$(9)